SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-000430
Filing Date
2021-01-08
Accepted
2021-01-08 17:22:07
Documents
22
Period of Report
2021-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20210108_8k.htm 8-K 32565
2 EXHIBIT 99.1 ex_220184.htm EX-99.1 12764
3 a01.jpg GRAPHIC 55835
4 a02.jpg GRAPHIC 71272
5 a03.jpg GRAPHIC 59817
6 a04.jpg GRAPHIC 63456
7 a05.jpg GRAPHIC 65606
8 a06.jpg GRAPHIC 59190
9 a07.jpg GRAPHIC 50500
10 a08.jpg GRAPHIC 46188
11 a09.jpg GRAPHIC 58599
12 a10.jpg GRAPHIC 60596
13 a11.jpg GRAPHIC 44986
14 a12.jpg GRAPHIC 27775
15 a13.jpg GRAPHIC 51207
16 a14.jpg GRAPHIC 50112
17 a15.jpg GRAPHIC 51470
18 a16.jpg GRAPHIC 56204
19 a17.jpg GRAPHIC 36619
20 a18.jpg GRAPHIC 34353
21 a19.jpg GRAPHIC 57621
22 a20.jpg GRAPHIC 38178
  Complete submission text file 0001437749-21-000430.txt   1476454
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 21518398
SIC: 2834 Pharmaceutical Preparations